Recurrence of Primary Cutaneous Anaplastic Large Cell Lymphoma at a New Location After Wide Surgical Excision

Main Article Content

Payvand Kamrani
Madeline Schaeffer
David Altman


Primary cutaneous CD30 anaplastic large cell lymphoma, PCALCL, lymphomatoid papulosis, LyP, anaplastic lymphoma kinase, ALK, reactive lymphoid hyperplasia


Abstract not available.


1. Baik BS, Lee WS, Ji SY, et al. Treatment of primary cutaneous anaplastic large cell lymphoma. Arch Craniofac Surg. 2019;20(3):207.

2. Vergier  B, Beylot-Barry  M, Pulford  K, et al.  Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. Am J Surg Pathol. 1998;22(10):1192-1202.

3. Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95(12):3653-3661.

4. Liu HL, Hoppe RT, Kohler S, et al. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol. 2003;49(6):1049-58.

5. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-85.

6. Kempf W, Pfaltz K, Vermeer MH, et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood. 2011:118(15):4024-4035.

7. Shehan, JM, Kalaaji AN, Markovic SN, et al. Management of multifocal primary cutaneous CD30+ anaplastic large cell lymphoma. J Am Acad Dermatol. 2004;51(1):103-110.

8. Moodley N, Nombona P, Mosam A. Primary Cutaneous Anaplastic Large-Cell Lymphoma. Dermatopathology, 2019;6(2):163-169.

9. Kang, S. K., Chang, S. E., Choi, J. H., Sung, K. J., Moon, K. C., & Koh, J. K. (2002). Coexistence of CD30‐positive anaplastic large cell lymphoma and mycosis fungoides. Clinical and experimental dermatology, 27(3), 212-215.

10. Werner Kempf, M. D., Katrin Kerl, M. D., & Christina Mitteldorf, M. D. (2018, March). Cutaneous CD30-positive T-cell lymphoproliferative disorders—clinical and histopathologic features, differential diagnosis, and treatment. In Seminars in cutaneous medicine and surgery (Vol. 37, pp. 24-29).